C1-esterase inhibitor in graft failure after lung transplantation

Intensive Care Medicine

Volumn 25, Issue 11, 1999, Pages 1315-1318

  Struber M ^a   Hagl, C ^a   Hirt, S W ^b   Cremer, J ^b   Harringer, W ^a   Haverich, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BERINERT; COMPLEMENT COMPONENT C1S INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LUNG SURFACTANT; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAPILLARY LEAK SYNDROME; CASE REPORT; COMPLEMENT ACTIVATION; EXTRACORPOREAL OXYGENATION; EXTUBATION; GRAFT FAILURE; HUMAN; LUNG FUNCTION; LUNG TRANSPLANTATION; MALE; PLEURA EFFUSION; REPERFUSION INJURY;

CAPILLARY LEAK SYNDROME; COMPLEMENT C1 INACTIVATOR PROTEINS; EXTRACORPOREAL MEMBRANE OXYGENATION; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PLEURAL EFFUSION; POSTOPERATIVE COMPLICATIONS;

EID: 0032757612     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340051065     Document Type: Article

References (8)

1. Nürnberger W, Petrik K, Burdach S, Göbel U (1994) C1 esterase inhibitor can reduce plasma concentrations of the complement activation product C5a. Intensive Care Med 20: 242-244
2. Hack CE, Ogilvie AC, Eisele B et al (1994) Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with vascular leak syndrome induced by interleukin-2 therapy. Prog Clin Biol Res 338: 335-357
3. Hack CE, Voerman HJ, Eisele B et al (1992) Cl-esterase inhibitor substitution in sepsis. Lancet 339: 378
4. Buerke M, Murohara T, Lefer AM (1995) Cardioprotective effects of C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91: 393-402
5. Guerro R, Velasco F, Rodriguez M et al (1993) Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor. J Clin Invest 91: 2754-2760
6. 1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog. Am J Respir Crit Care Med 155: 1147-1154
7. Zenati M, Pham SM, Keenan RJ, Griffith BP (1996) Extracorporal membrane oxygenation for lung transplant recipients with primary severe donor lung dysfunction. Transpl Int 9: 227-230
8. Steinberg JB, Kapelanski DR Olson JD, Weiler JM (1993) Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106: 1008-1016